COMMUNIQUÉS West-GlobeNewswire

Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
15/05/2024
Topline data from Phase 2/3 LIFT-AD clinical trial of fosgonimeton as a potential treatment for mild-to-moderate Alzheimer’s disease expected in second half of 2024 Submitted Investigational New Drug application to U.S [...]
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
15/05/2024
Combination and monotherapy solid tumor dose escalation data for CLN-619 to be presented in a poster session at ASCO 2024 Annual Meeting CLN-978 development to focus exclusively on autoimmune diseases, starting with [...]
OrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Annual Meeting
15/05/2024
Reinforced Long-Term Commitment as Emerald Sponsor WARSAW, Ind., May 15, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of [...]
Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
15/05/2024
Patient enrollment underway in sunRIZE global Phase 3 clinical study of RZ358 in patients with congenital hyperinsulinism (cHI); topline results expected in mid-2025 Completed in-vivo toxicology study in brown Norway [...]
Oncocyte Reports First Quarter 2024 Financial Results
15/05/2024
Conference Call on Wednesday, May 15, 2024 at 1:30 p.m. PT / 4:30 p.m. ET IRVINE, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial [...]
Inotiv Reports Second Quarter Financial Results for Fiscal 2024 and Provides Business Update
15/05/2024
— Second quarter fiscal 2024 revenue down 21.5% to $119.0 million — Year-to-date fiscal 2024 revenue down 7.2% to $254.5 million — Agreement in principle reached with the U.S. Department of Justice on related matter — [...]
AB Science reports its revenues for the year 2023 and provides an update on its activities
15/05/2024
PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2023 AND THE KEY EVENTS OF THE PERIOD Clinical development Continuation of the conditional marketing authorisation application procedures [...]
AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2023 et présente un point sur ses activités
15/05/2024
COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS ANNUELS AU 31 DECEMBRE 2023 ET LES EVENEMENTS CLEFS DE LA PERIODE Développement clinique Poursuite des procédures de demande d’autorisation [...]
60 Degrees Pharmaceuticals Announces First Quarter 2024 Results
15/05/2024
Q1 2024 net product revenues increased 515% year-over-year to $105.7 thousand. Gross profit increased from ($55.9 thousand) to $51.0 thousand. WASHINGTON, May 15, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc [...]
Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
15/05/2024
DALLAS, May 15, 2024 (GLOBE NEWSWIRE) -- New research from The Cooper Institute® and partners at University of Texas (UT) Southwestern Medical Center, The University of Texas at Tyler and University of Alabama at [...]
HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study
15/05/2024
MOUNTAIN VIEW, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, today announced that the data from its REVEALPLAQUE study, [...]
PHAXIAM provides Business and Financial Update for the First Quarter of 2024
15/05/2024
PHAXIAM provides Business and Financial Update for the First Quarter of 2024 Webinar (in French) today, May 15, 2024, at 6.00 pm CEST Accelerated clinical efforts to roll-out PHAXIAM’s strategy in order to create a [...]
PHAXIAM Therapeutics fait le point sur ses activités et publie l’information financière du premier trimestre 2024
15/05/2024
PHAXIAM Therapeutics fait le point sur ses activités et publie l’information financière du premier trimestre 2024 Webinaire (en français) ce jour à 18h00 : inscrivez-vous ici Accélération des développements cliniques en [...]
Ezra Partners with Princeton Radiology for Proactive, Whole-Body MRI Screenings to Support Earlier Cancer Detection
15/05/2024
NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- Ezra , the healthcare AI startup transforming early cancer detection through full body MRI screening, today announced a new partnership with Princeton Radiology Associates, [...]
Mathew Hall, Sarcoidosis Warrior, Takes on Iron Man 70.3 Chattanooga to Raise Awareness and Support for Sarcoidosis
15/05/2024
CHICAGO, May 15, 2024 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) proudly announces Mathew Hall, a devoted supporter and sarcoidosis patient, will be competing in the upcoming Ironman 70.3 [...]
Novartis highlights pioneering innovation in CML with data from Scemblix® Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHA
15/05/2024
Primary results of the Scemblix ® ASC4FIRST pivotal Phase III study in first-line Ph+ CML-CP supporting third US FDA Breakthrough Therapy designation, to be detailed in the ASCO Press Program and the EHA Plenary Session [...]
Dew Aesthetics Unveils Cutting-Edge MedSpa Treatments in Baltimore, Pioneering a Path to Timeless Beauty
15/05/2024
BALTIMORE, Md., May 15, 2024 (GLOBE NEWSWIRE) -- Dew Aesthetics , the premier destination for cutting-edge medical spa treatments, is proud to announce the launch of its innovative services, revolutionizing the [...]
Dr. Bob Meyer D.C. Legacy in Sports Medicine Continues to Shine Bright: A Testament to Excellence
15/05/2024
AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) -- In the fast-paced world of sports medicine, few names command as much respect and admiration as Dr. Bob Meyer, D.C. With a career spanning decades, Dr. Bob has not only [...]
Alvotech S.A. Annual General Meeting to be held June 7, 2024
15/05/2024
The Annual General Meeting of Alvotech S.A. will be held on Friday June 7, 2024, at 09.00 a.m. CEST at the premises of Arendt & Medernach S.A. at 41A, Avenue John F. Kennedy L-1855 Luxembourg, Grand Duchy of [...]

Pages